Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | +36.36% | +121.24% | -95.03% |
Apr. 15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 529K |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | - |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.29% |
Latest transcript on Acorda Therapeutics, Inc.
1 week | +62.24% | ||
Current month | -95.84% | ||
1 month | -95.45% | ||
3 months | -96.81% | ||
6 months | -94.57% | ||
Current year | -96.36% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.75 | +36.36% | 37 616 |
24-04-24 | 0.55 | +5.77% | 63,391 |
24-04-23 | 0.52 | +13.04% | 70,030 |
24-04-22 | 0.46 | +4.55% | 44,844 |
24-04-19 | 0.44 | +15.79% | 40,189 |
Delayed Quote Nasdaq, April 24, 2024 at 03:52 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+0.55% | 22.2B | |
-16.53% | 21.23B | |
-10.60% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock